Europe Dry Eye Syndrome Market PPT: Growth, Outlook, Demand, Keyplayer Analysis and Opportunity 2023-28

1
Europe Dry Eye Syndrome Market Research and
Forecast Report 2023-2028




Author Elena Anderson Marketing Manager IMARC
Group
2022 IMARC All Rights Reserved
Copyright IMARC Service Pvt Ltd. All Rights
Reserved
2
About IMARC Group
Report Description
International Market Analysis Research and
Consulting Group is a leading adviser on
management strategy and market research
worldwide. We partner with clients in all regions
and industry verticals to identify their
highest-value opportunities, address their most
critical challenges, and transform their
businesses. IMARCs information products include
major market, scientific, economic and
technological developments for business leaders
in pharmaceutical, industrial, and high
technology organizations. Market forecasts and
industry analysis for biotechnology, advanced
materials, chemicals, food and beverage, travel
and tourism, nanotechnology and novel processing
methods are at the top of the companys
expertise. IMARCs tailored approach combines
unfathomable insight into the dynamics of
companies and markets with close cooperation at
all levels of the client organization. This
ensures that our clients achieve unmatchable
competitive advantage, build more proficient
organizations, and secure lasting results.
3
Report Description and Highlights
Report Description
Europe Dry Eye Syndrome Market Research Report
2023-2028 According to the latest report by
IMARC Group, titled "Europe Dry Eye Syndrome
Market Industry Trends, Share, Size, Growth,
Opportunity and Forecast 2023-2028," the Europe
dry eye syndrome market size reached US 719
Million in 2022. Dry eye syndrome (DES), also
known as keratoconjunctivitis sicca (KCS), is a
medical condition that occurs due to the lack of
moisture or lubrication on the surface of the
eye. It is characterized by symptoms, including
irritation, redness, discharge, fatigued eyes,
and blurred vision. It is caused by various
reasons such as hormone changes, autoimmune
disease, inflamed eyelid glands, allergic eye
disease, extensive computer usage, and medication
that disrupt the healthy tear film. However, dry
eye syndrome can be treated through administering
artificial tears, medications, lacrimal plugs,
and surgeries. Request for a PDF sample of this
report https//www.imarcgroup.com/europe-dry-eye-
syndrome-market/requestsample

4
Report Description and Highlights
Report Description
Europe Dry Eye Syndrome Market Trends The
rising geriatric population, which is more
susceptible to chronic eye diseases, is one of
the key factors driving the market growth. Dry
eye syndrome is also caused by various other
medical conditions, such as Sjogrens syndrome,
lupus, scleroderma, rheumatoid arthritis,
sarcoidosis, thyroid disorders, and diabetes,
which is highly prevalent among elderly patients.
In addition, sedentary lifestyles and a lack of
physical activities of the masses are leading to
increased oxidative stress and reduced mucin
expression in the eyes. As a result, patients
and healthcare providers are widely adopting
corticosteroid drugs to effectively treat dry eye
syndrome,. Furthermore, the improving diagnostic
technologies, rising healthcare expenditure
capacities of consumers, and increasing
utilization of smartphones, laptops and
television among the masses leading to prolonged
and excessive screen time are some of the other
factors creating a positive market outlook across
the region.   Looking forward, IMARC Group
expects the market value to reach US 986 Million
by 2028, exhibiting a CAGR of 5.3 during the
forecast period (2023-2028). View Report TOC,
Figures and Tables https//www.imarcgroup.com/eur
ope-dry-eye-syndrome-market

5
Report Description and Highlights
Report Description

• Key Market Segmentation
• The research report includes the following
  segments
• Breakup by Disease Type
• Evaporative Dry Eye Syndrome
• Aqueous Dry Eye Syndrome
•  
• Breakup by Drug Type
• Anti-inflammatory Drugs
• Lubricant Eye Drops
• Autologous Serum Eye Drops
• Breakup by Product
• Liquid Drops
• Gel
• Liquid Wipes
• Eye Ointment
• Others

6
Report Description and Highlights
Report Description

• Breakup by Distribution Channel
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
•  
• Breakup by Country
• Germany
• France
• United Kingdom
• Italy
• Spain
• Others

7
Key Questions Answered in the Report
Report Description

•  
• How has the Europe dry eye syndrome market
  performed so far and how will it perform in the
  coming years?
• What has been the impact of COVID-19 on the
  Europe dry eye syndrome market?
• What are the key regional markets?
• What is the breakup of the market based on the
  disease type?
• What is the breakup of the market based on the
  drug type?
• What is the breakup of the market based on the
  product?
• What is the breakup of the market based on the
  distribution channel?
• What are the various stages in the value chain of
  the industry?
• What are the key driving factors and challenges
  in the industry?
• What is the structure of the Europe dry eye
  syndrome market and who are the key players?
• What is the degree of competition in the industry?

8
Table of Contents
Report Description
1   Preface 2    Scope and Methodology     2.1
   Objectives of the Study    2.2  
 Stakeholders    2.3    Data Sources       
2.3.1    Primary Sources        2.3.2  
 Secondary Sources    2.4    Market Estimation 
      2.4.1    Bottom-Up Approach        2.4.2  
 Top-Down Approach    2.5    Forecasting
Methodology3    Executive Summary4  
 Introduction    4.1    Overview    4.2    Key
Industry Trends5    Europe Dry Eye Syndrome
Market    5.1    Market Overview    5.2  
 Market Performance    5.3    Impact of
COVID-19    5.4    Market Forecast

9
Table of Contents
Report Description
6    Market Breakup by Disease Type     6.1    
Evaporative Dry Eye Syndrome        6.1.1 Market
Trends        6.1.2 Market Forecast    6.2    
Aqueous Dry Eye Syndrome        6.2.1 Market
Trends        6.2.2 Market Forecast7    Market
Breakup by Drug Type    7.1    
Anti-inflammatory Drugs        7.1.1 Market
Trends        7.1.2 Market Forecast    7.2    
Lubricant Eye Drops        7.2.1 Market Trends 
      7.2.2 Market Forecast    7.3    
Autologous Serum Eye Drops        7.3.1 Market
Trends        7.3.2 Market Forecast Click here
to visit the complete table of content with list
of figures and tables https//www.imarcgroup.com/
europe-dry-eye-syndrome-market/toc

10
Partial List of Clients
We are the trusted business partners to the
world's leading corporates, governments, and
institutions
A partial List of our Clients
11
Partial List of Clients
We are the trusted business partners to the
world's leading corporates, governments, and
institutions
A partial List of our Clients
12
Report Description and Highlights
Report Description

2022 IMARC All Rights Reserved This
Publication and all its contents unless
otherwise mentioned are copyrighted in the name
of International Market Analysis Research and
Consulting (IMARC). No part of this publication
may be reproduced, repackaged, redistributed or
resold in whole or in any part. The publication
may also not be used in any form or by and means
graphic electronic or mechanical, including
photocopying, recording, taping or by information
storage or retrieval, or by any other form,
without the express consent of International
Market Analysis Research and Consulting
(IMARC). Disclaimer All contents and data of
this publication, including forecasts, data
analysis and opinion have been based on
information and sources believed to be accurate
and reliable at the time of publishing.
International Market Analysis Research and
Consulting makes no representation of warranty of
any kind as to the accuracy or completeness of
any Information provided. IMARC accepts no
liability whatsoever for any loss or damage
resulting from opinion, errors or inaccuracies if
any found this publication. IMARC, IMARC Group
and Global Therapy Insight Series are registered
trademarks of International Market Analysis
Research and Consulting. All other trademarks
used in this publication are registered
trademarks of their respective companies.
13

Contact Us